Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
Case Reports in Nephrology and Dialysis · 31.03.2021 · 11 (1) · 95-102
DOI: 10.1159/000512227 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Nephrology and Dialysis, online erschienen am 31.03.2021. Verfasst von Everardo Arias Torres und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, Irvine, California, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Thrombotic microangiopathies (TMAs) involve multiple organ systems due to the presence of microangiopathic hemolysis. One such condition, atypical hemolytic uremic syndrome (aHUS), is a complement-mediated process that is part of a spectrum of disorders that have underlying complement dysfunction of the alternative pathway due to overactivity or decreased self-nonself discrimination by innate immunity. Complement-amplifying conditions such as pregnancy may unmask a diagnosis of aHUS. We present an important case of a pregnant 23-year-old Hispanic female who presented in mid-gestation (21 weeks) with an initial diagnosis of systemic lupus erythematosus (SLE) complicated by aHUS. She met clinical criteria for aHUS on presentation and was found to have a pathogenic CFHR1–3 homozygous deletion. She has been treated with intravenous and oral steroids, cyclophosphamide, subsequently also with plasma exchange, and finally with eculizumab with partial improvement in renal function. This case adds to the emerging literature showing that SLE and aHUS (or complement-mediated TMA) can be successfully treated with C5 blockade.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of California, Irvine, California, USA.
- Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California, Irvine, California, USA.
- Division of Rheumatology, Department of Medicine, University of California, Irvine, California, USA.
- Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA.
- Department of Obstetrics and Gynecology, Maternal-Fetal Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA.
Zitieren
APA
Torres, E. A., Chang, Y., Desai, S., Chang, I., Zuckerman, J. E., Burwick, R., Kalantar-Zadeh, K., & Hanna, R. M. (2021). Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report. Case Reports in Nephrology and Dialysis, 11(1), 95-102. https://doi.org/10.1159/000512227
Vancouver
Torres EA, Chang Y, Desai S, Chang I, Zuckerman JE, Burwick R, et al. Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report. Case Reports in Nephrology and Dialysis. 2021;11(1):95-102. doi:10.1159/000512227
BibTeX
@article{Torres2021,
author = {Torres, Everardo Arias and Chang, Yongen and Desai, Sheetal and Chang, Ian and Zuckerman, Jonathan E and Burwick, Richard and Kalantar-Zadeh, Kamyar and Hanna, Ramy M},
title = {Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report},
journal = {Case Reports in Nephrology and Dialysis},
year = {2021},
volume = {11},
number = {1},
pages = {95--102},
doi = {10.1159/000512227}
}
EUVIMED